Search results: Sage Journals

Restricted accessReview articleFirst published September, 2022

Management of Myeloproliferative Neoplasms (MPNs)

Zubeir Nurgat, Myer Lawrence

Journal of Oncology Pharmacy Practice

Open accessResearch articleFirst published March, 2023

The Combination of JAK2V617F Allele Burden and WT1 Expression can Be Helpful in Distinguishing the Subtype of MPN Patients

Sanyun Wu, Ping Luo, Tuerxunayi Rouzi [...]

Cancer Control

Open accessResearch articleFirst published 2026

Citrullinated Histone 3 as a Marker of NETosis at Opposite Ends of Hemostasis: Evidence From Thrombosis-Prone MPN and Bleeding-Prone Hemophilia

Sercan Olcar, Tuğrul Elverdi, İbrahim Murat Bolayırlı [...]

Clinical and Applied Thrombosis/Hemostasis

Open accessCase reportFirst published 2026

A Hidden Driver Mutation in Myeloproliferative Neoplasms: SH2B3 and Diagnostic Implications and Response to Ropeginterferon Alfa-2b

Karina Basmajian, Lauren Rachel Chang Borecky, Mojtaba Akhtari

Journal of Investigative Medicine High Impact Case Reports

Free accessResearch articleFirst published November, 2016

Coexistence of lymphoproliferative and myeloproliferative neoplasms with simultaneous CALR and JAK2 V617F mutations

Hai-Su Yang

Cancer Biomarkers

Open accessResearch articleFirst published 2022

Association Between Cancer-Related Fatigue and Falls in Patients With Myeloproliferative Neoplasms: Results of a Multicenter Cross-Sectional Survey From the East German Study Group for Hematology and Oncology (OSHO #97)

Sabine Felser, Martin Gube, Julia Gruen [...]

Integrative Cancer Therapies

Open accessResearch articleFirst published 2026

PD-1/PD-L1-CXCR3 Coexpression and CXCR3 on Intermediate Monocytes Predict Fibrosis,Leukemic Transformation,and Survival in Egyptian Philadelphia-Negative Myeloproliferative Neoplasms

Dalia E Sherief, Rawan Ahmed Elmezien, Nahla Nosair [...]

Clinical Medicine Insights: Oncology

Open accessResearch articleFirst published 2026

Heterogeneity among patients with myeloproliferative neoplasms: Identifying distinct profiles through cluster analysis

Annemiek A. M. Eppingbroek, Lilian Lechner, Moniek A. de Witte [...]

Journal of Health Psychology

Open accessBrief reportFirst published 2026

Ruxolitinib treatment in patients with polycythemia vera reduces JAK2 variant allele frequency and improves symptom burden and hematocrit control

Claire N. Harrison, Jean-Jacques Kiladjian, J. E. Hamer-Maansson [...]

Therapeutic Advances in Hematology

Free accessResearch articleFirst published November 19, 2020

m-polar Neutrosophic Generalized Weighted and m-polar Neutrosophic Generalized Einstein Weighted Aggregation Operators to Diagnose Coronavirus (COVID-19)

Masooma Raza Hashmi, Muhammad Riaz, Florentin Smarandache

Journal of Intelligent & Fuzzy Systems: Applications in Engineering and Technology

Restricted accessReview articleFirst published September, 2022

Management of Myeloproliferative Neoplasms (MPNs)

Zubeir Nurgat, Myer Lawrence

Journal of Oncology Pharmacy Practice

Open accessResearch articleFirst published March, 2023

The Combination of JAK2V617F Allele Burden and WT1 Expression can Be Helpful in Distinguishing the Subtype of MPN Patients

Sanyun Wu, Ping Luo, Tuerxunayi Rouzi [...]

Cancer Control

Open accessResearch articleFirst published 2026

Citrullinated Histone 3 as a Marker of NETosis at Opposite Ends of Hemostasis: Evidence From Thrombosis-Prone MPN and Bleeding-Prone Hemophilia

Sercan Olcar, Tuğrul Elverdi, İbrahim Murat Bolayırlı [...]

Clinical and Applied Thrombosis/Hemostasis

Open accessCase reportFirst published 2026

A Hidden Driver Mutation in Myeloproliferative Neoplasms: SH2B3 and Diagnostic Implications and Response to Ropeginterferon Alfa-2b

Karina Basmajian, Lauren Rachel Chang Borecky, Mojtaba Akhtari

Journal of Investigative Medicine High Impact Case Reports

Free accessResearch articleFirst published November, 2016

Coexistence of lymphoproliferative and myeloproliferative neoplasms with simultaneous CALR and JAK2 V617F mutations

Hai-Su Yang

Cancer Biomarkers

Open accessResearch articleFirst published 2022

Association Between Cancer-Related Fatigue and Falls in Patients With Myeloproliferative Neoplasms: Results of a Multicenter Cross-Sectional Survey From the East German Study Group for Hematology and Oncology (OSHO #97)

Sabine Felser, Martin Gube, Julia Gruen [...]

Integrative Cancer Therapies

Open accessResearch articleFirst published 2026

PD-1/PD-L1-CXCR3 Coexpression and CXCR3 on Intermediate Monocytes Predict Fibrosis,Leukemic Transformation,and Survival in Egyptian Philadelphia-Negative Myeloproliferative Neoplasms

Dalia E Sherief, Rawan Ahmed Elmezien, Nahla Nosair [...]

Clinical Medicine Insights: Oncology

Open accessResearch articleFirst published 2026

Heterogeneity among patients with myeloproliferative neoplasms: Identifying distinct profiles through cluster analysis

Annemiek A. M. Eppingbroek, Lilian Lechner, Moniek A. de Witte [...]

Journal of Health Psychology

Open accessBrief reportFirst published 2026

Ruxolitinib treatment in patients with polycythemia vera reduces JAK2 variant allele frequency and improves symptom burden and hematocrit control

Claire N. Harrison, Jean-Jacques Kiladjian, J. E. Hamer-Maansson [...]

Therapeutic Advances in Hematology

Free accessResearch articleFirst published November 19, 2020

m-polar Neutrosophic Generalized Weighted and m-polar Neutrosophic Generalized Einstein Weighted Aggregation Operators to Diagnose Coronavirus (COVID-19)

Masooma Raza Hashmi, Muhammad Riaz, Florentin Smarandache

Journal of Intelligent & Fuzzy Systems: Applications in Engineering and Technology